Diagnostic accuracy of 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: A cross-sectional study

Journal of Nuclear Medicine

Volumn 57, Issue 11, 2016, Pages 1726-1732

  Granados, Ulises ^a   Fuster, David ^a,b   Pericas, Juan M ^a,b   Llopis, Jaime L ^b   Ninot, Salvador ^a,b   Quintana, Eduard ^a,b   Almela, Manel ^a   Pari, Carlos ^a,b   Tolosana, José M ^a,b   Falces, Carlos ^a,b   Moreno, Asuncion ^a,b   Pons, Francesca ^a,b   Lomẽna, Francisco ^a,b   Miro, Jose M ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

18F FDG PET CT; Implantable cardiac electronic devices; Infective endocarditis; Prosthetic valve; Septic embolisms

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEPARIN; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; BACTERIAL ENDOCARDITIS; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CROSS-SECTIONAL STUDY; DEVICE INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOCARDIOGRAPHY; EMBOLISM; FALSE NEGATIVE RESULT; FEMALE; GENDER; HEART VALVE PROSTHESIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; ADULT; ADVERSE DEVICE EFFECT; ARTIFICIAL HEART PACEMAKER; DIAGNOSTIC IMAGING; ENDOCARDITIS; EVIDENCE BASED MEDICINE; IMAGE ENHANCEMENT; MIDDLE AGED; OBSERVER VARIATION; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS; EVIDENCE-BASED MEDICINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; OBSERVER VARIATION; PACEMAKER, ARTIFICIAL; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84994884982     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.116.173690     Document Type: Article

References (25)

1. Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;368:1425-1433.
2. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:965-975.
3. Chambers J, Sandoe J, Ray S, et al. The infective endocarditis team: recommendations from an international working group. Heart. 2014;100:524-527.
4. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
5. Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33: 2023-2029.
6. Habib G, Badano L, tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11:202-219.
7. Habib G, Lancelloti, Antunes MJ, et al. Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-3128.
8. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435-1486.
9. Gupta A, Madani R, Mukhtar H. Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis. 2010;12:164-171.
10. Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A. The use of 18F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases (review article). Clin Dev Immunol. August 21, 2013 [Epub ahead of print].
11. Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis. 2012;54:1333-1341.
12. Ishimori T, Saga T, Mamede M, et al. Increased 18F-FDG uptake in a model of inflammation: concanavalin A mediated lymphocyte activation. J Nucl Med. 2002; 43:658-663.
13. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine- 18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33: 1972-1980.
14. Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18Ffluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013; 61:2374-2382.
15. Graziosi M, Nanni C, Lorenzini M, et al. Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study. Eur J Nucl Med Mol Imaging. 2014;41:1617-1623.
16. Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59: 1616-1625.
17. Kestler M, Mũnoz P, Rodríguez-Créixems M, et al. Role of 18F-FDG PET in patients with infectious endocarditis. J Nucl Med. 2014;55:1093-1098.
18. Orvin K, Goldber E, Bernstine H, et al. The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis. Clin Microbiol Infect. 2015;21:69-76.
19. Mestres CA, Paré JC, Miró JM. Organization and functioning of a multidisciplinary team for the diagnosis and treatment of infective endocarditis: A 30-year perspective (1985-2014). Rev Esp Cardiol. 2015;68:363-368.
20. Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70:325-359.
21. Erba PA, Conti U, Lazzeri E, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med. 2012;53:1235-1243.
22. Williams G, Kolodny G. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR. 2008;190: W151-W156.
23. Scholtens AM, Verberne HJ, Budde RP, Lam M. Additional heparin pre-Administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging. J Nucl Med. 2016;57:568-573.
24. Pizzi MN, Roque A, Fernández-Hidalgo N, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18Ffluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation. 2015;132:1113-1126.
25. Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue. Curr Cardiol Rep. 2014;16:459.